Table 3 Comparison of the proportions of patients with different numbers of AAbs between groups.
The number of positive-AAbs in ANAs | SLE group (n = 148) | Non-SLE rheumatic diseases group (n = 317) | Nephropathy group (n = 99) | Hematological diseases group (n = 210) | Other diseases group (n = 523) |
|---|---|---|---|---|---|
0, n (%) | 9 (6.08) | 182 (57.41) | 94 (94.95) | 180 (85.71) | 467 (89.29) |
0.5, n (%) | 0 | 0 | 0 | 0 | 1 (0.19) |
≥ 1, n (%) | 139 (93.92*) | 135 (42.59*) | 5 (5.05) | 30 (14.29) | 55 (10.52) |
≥ 2, n (%) | 114 (77.03*) | 47 (14.83*) | 0 | 5 (2.38) | 6 (1.15) |
≥ 3, n (%) | 75 (50.68▲) | 8 (2.52) | 0 | 0 | 0 |
≥ 4, n (%) | 48 (32.43) | 4 (1.26) | 0 | 0 | 0 |
